New study reveals promising strategy to retrain neutrophils to target breast cancer

Researchers have discovered a novel way to retrain neutrophils—the body’s first responders—to directly attack aggressive breast cancer cells, offering new hope to patients unresponsive to current immunotherapies.

New study reveals promising strategy to retrain neutrophils to target breast cancer